Similarly, the enrichment of CD133+ cells in lung adenocarcinoma after cisplatin induction leads to multidrug resistance through activation of Notch signaling as higher levels of cleaved Notch1 (NICD1) are detected [170]. The gene discussed is NOTCH1; the disease is lung adenocarcinoma.